委内瑞拉马类脑炎病毒对抗cGAS-STING通路
Brittany N Heath1,2, Maryna Akhrymuk1, Abdullahi T Jamiu1,2
1Department of Biomedical Sciences and Pathobiology, Virginia-Maryland College of Veterinary Medicine, Virginia Polytechnic Institute and State University, Blacksburg, VA 24061, USA.
Cells
|February 26, 2026
概括
委内瑞拉马脑炎病毒 (VEEV) 反对干扰素基因 (cGAS-STING) 循环GMP-AMP合成酶刺激途径. 在感染之前启动STING限制了VEEV复制,但感染后的向是无效的.
科学领域:
- 病毒学 病毒学
- 免疫学 免疫学 免疫学
- 分子生物学分子生物学
背景情况:
- 委内瑞拉马脑炎病毒 (VEEV) 导致人类显著的发病率,包括神经复发症.
- 干扰素基因 (cGAS-STING) 的循环GMP-AMP合成酶刺激通路对于抗病毒免疫至关重要,对病毒病原体作出反应.
- 虽然cGAS-STING限制了一些RNA病毒,但它在新世界阿尔法病毒感染 (如VEEV) 中的作用尚不清楚.
研究的目的:
- 调查STING激活对VEEV感染的影响.
- 探索STING激活作为潜在的预防和治疗策略来对抗VEEV.
- 为了确定VEEV是否对抗cGAS-STING信号通路.
主要方法:
- 在VEEV感染期间研究了STING酸化 (Ser366) 和干扰素刺激基因 (ISG) 上调.
- 利用siRNA来评估VEEV感染中的STING依赖性.
- 研究了在VEEV感染前和感染后的STING通路原始化和向的影响.
- 在各种多重感染 (MOI) 时检查了STING酸化抑制.
主要成果:
- 仅VEEV感染本身并没有诱导STING酸化,但ISG在感染后期被上调.
- STING损失部分损害了ISG转录,这表明非正规的STING激活.
- 在感染之前启动STING通路对于限制VEEV复制至关重要.
- 感染后的STING激活针对已废除的dsDNA抗病毒效应.
- 维埃维以MOI依赖的方式抑制了STING酸化,在MOI10处显著抑制.
结论:
- 在VEEV感染时,cGAS-STING通路并没有被正式激活.
- 在剂量取决的方式中,VEEV积极对抗正规的STING激活.
- STING通路原始化显示出作为对VEEV的预防措施的潜力,但感染后向是无效的.
相关概念视频
Antiepileptic Drugs: GABAergic Pathway Potentiators
1.5K
γ-aminobutyric acid or GABA, plays a pivotal role as an inhibitory neurotransmitter in the brain. GABA pathway potentiators, also known as GABAergic drugs, are a class of pharmaceutical agents designed to enhance the functioning of the GABAergic system. These medications primarily treat epilepsy, a neurological disorder characterized by recurrent seizures.
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
1.5K
Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein
1.0K
Antiepileptic drugs, such as levetiracetam (Keppra) and brivaracetam (Briviact), have emerged as crucial tools in managing epilepsy. These medications exert their therapeutic effects by targeting the synaptic vesicle protein SV2A, a transmembrane glycoprotein primarily found in the brain.
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
1.0K
GPCRs Regulate Adenylyl Cylase Activity
7.8K
Some GPCRs transmit signals through adenylyl cyclase (AC), a transmembrane enzyme. AC helps synthesize second messenger cyclic adenosine monophosphate (cAMP). AC catalyzes cyclization reaction and converts ATP to cAMP by releasing a pyrophosphate. The pyrophosphate is further hydrolyzed to phosphate by the enzyme pyrophosphatase, which drives cAMP synthesis to completion. However, cAMP is rapidly degraded to 5′ AMP by the enzymes phosphodiesterase (PDE), preventing overstimulation of...
7.8K


